ZENTIVA
86 articole · RSS
Zentiva Net Profit Doubles YoY To RON41M In 1H/2020
Pharmaceutical producer Zentiva Romania (SCD.RO) registered a turnover of RON281 million in the first half of 2020, close to the RON284.9 million level reported in the same period in 2019, p...
Zentiva Romania Posts RON46.3M Profit in 2019
Pharmaceutical producer Zentiva Romania (SCD.RO), 95.9% owned by Czech Zentiva Group, said Thursdy its turnover grew 16% in 2019, to RON535.4 million, and it made a profit of RON46.3 million...
Zentiva Completes Acquisition of Alvogen's CEE Operations Including Romanian Labormed
Zentiva Group, owned by Advent International, announced Tuesday it has completed the acquisition of Alvogen's Central and Eastern European (CEE) business.
Zentiva Appoints New Provisional Director
Pharmaceutical producer Zentiva (SCD.RO), owned by Czech Zentiva Group, said Tuesday it has appointed Kenneth Lynard as provisional director as of October 1, following the resignation of Ble...
Zentiva Boosts Share Capital By RON28M To RON69.7M
Pharmaceutical producer Zentiva Romania (SCD.RO), 93.2% owned by Czech Zentiva Group, said it registered on September 9 the increase of its share capital by RON28 million, to RON69.7 million...
Zentiva 1H Net Profit Grows 36%, to RON49M
Pharmaceutical producer Zentiva Romania (SCD.RO), 95.9% owned by Czech Zentiva Group, on Wednesday reported a net profit of RON48.9 million, up 36% on the year.
Zentiva Gets Antitrust Clearance to Buy Solacium Brand from A&D Pharma
Romania's antitrust body has cleared the deal whereby generics manufacturer Zentiva, owned by Advent International, took over the Romanian food supplement brand Solacium from A&D Pharma, own...
Zentiva Net Profit Nearly Triples in 1Q, To RON32.5M
Generics manufacturer Zentiva on Wednesday reported a net profit of RON32.5 million for the first quarter, nearly triple compared with the RON12 million net profit posted in the same period...
Zentiva Invests Over RON27M In Generic Drug Production In 2018
Drugmaker Zentiva invested RON27.7 million in manufacturing and developing generic drugs in 2018, managing to boost by 12.5% the production capacity at its factory in capital city Bucharest...